Does Insurance Cover Ozempic? 2026 Guide

Section 1: What Is Ozempic Approved For?

Ozempic (semaglutide 0.5 mg, 1 mg, and 2 mg once-weekly injection) holds three FDA-approved indications:

• ✓
  Type 2 diabetes: To improve glycemic control in adults with Type 2 diabetes mellitus, used alongside diet and exercise.
• ✓
  Cardiovascular risk reduction: To reduce the risk of major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with Type 2 diabetes and established cardiovascular disease.
• ⚠
  Not approved for weight loss: Ozempic does not carry a weight-loss indication. Wegovy (semaglutide 2.4 mg) is the FDA-approved formulation for chronic weight management. Insurers will generally not cover Ozempic for off-label weight loss — and prior authorization will be denied if the diagnosis code does not match an approved indication.

Section 2: How Coverage Is Typically Structured

Formulary tier placement

Ozempic is classified as a specialty or brand-name medication and typically appears on Tier 3 or Tier 4 of most commercial formularies. This means your share of cost is higher than for generic or preferred-brand drugs. Some plans place it on a specialty tier that applies coinsurance rather than a fixed copay. Formulary placement determines not just cost but also which utilization management rules apply.

Prior authorization criteria

Nearly all plans require prior authorization (PA) for Ozempic. Standard documentation requirements include:

• Confirmed Type 2 diabetes diagnosis (ICD-10 code E11.x) with supporting lab results
• A1C of 7.0% or above within the past 3 months (some plans require 6.5%+)
• Documented trial of first-line agents (most commonly metformin, 90 days at maximum tolerated dose)
• Clinical notes from the prescribing physician explaining medical necessity
• Patient demographic and insurance information

Standard PA decisions take 3 to 14 business days. Urgent requests can be processed in 24 to 72 hours. Authorization periods typically run 6 to 12 months, after which reauthorization is required.

Step therapy

Many plans require step therapy — sometimes called "fail first" — meaning you must document use of and inadequate response to less expensive diabetes medications before Ozempic will be approved. Common step therapy sequences require:

• Step 1: Metformin (90+ days at maximum tolerated dose)
• Step 2: A sulfonylurea, DPP-4 inhibitor, or SGLT-2 inhibitor (plan-dependent)
• Documentation of clinical failure, intolerance, or contraindication for each prior step

Patients with contraindications to step-required medications (e.g., kidney disease precluding metformin) may qualify for a step therapy waiver with appropriate documentation.

Section 3: Typical Out-of-Pocket Cost with Insurance

The list price for Ozempic is approximately $1,028 per month before insurance. Your actual cost depends on your plan's cost-sharing structure:

Section 4: Common Reasons for Denial and How to Appeal

Common denial reasons

• 1
  Wrong indication code: Prescription submitted with a weight-loss or off-label diagnosis code rather than a diabetes or cardiovascular code.
• 2
  Incomplete documentation: Missing A1C results, incomplete prior treatment history, or unsigned PA forms.
• 3
  Step therapy not completed: No documented trial of metformin or other required first-line agents, or duration was insufficient.
• 4
  Not on formulary: Your plan's formulary excludes Ozempic entirely for your benefit type or plan year.
• 5
  Expired prior authorization: Reauthorization was not submitted before the prior PA period expired.

How to appeal

1. Request the denial explanation in writing (your Explanation of Benefits or denial letter).
2. Identify the specific denial reason — this determines what supporting documentation you need.
3. Work with your prescriber to prepare a medical necessity letter addressing the denial reason directly.
4. Include supporting clinical documentation: A1C history, comorbidities, prior treatment records.
5. Submit the appeal within your plan's deadline — typically 60 to 180 days from the denial notice.
6. Request an expedited appeal if you are currently without medication.

Data from insurers suggests appeal success rates increase significantly when clinical documentation includes A1C levels, comorbidities such as cardiovascular disease or kidney disease, and evidence of prior treatment failures. Peer-to-peer review (your doctor speaking directly with the insurer's medical director) can also improve outcomes.

Section 5: Novo Nordisk Savings Programs for Ozempic

Novo Nordisk operates two programs that can reduce Ozempic costs for eligible patients:

Section 6: If Your Insurance Does Not Cover Ozempic

If coverage is denied or unavailable, several telehealth providers offer GLP-1 access with transparent, all-inclusive pricing. These providers work with licensed prescribers and ship directly to your home.

Advertising disclosure: The telehealth options below are paid sponsors. We may earn a commission when you sign up. This does not affect your pricing. Listing order does not imply medical recommendation. Always consult a licensed healthcare provider.

Section 7: Frequently Asked Questions